Figure 3Figure 3
Mechanisms of melatonin regulation in neurodegenerative diseases. This schematic illustrates the disease-specific regulatory actions of melatonin in Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and prion diseases.